MedPath

Prospective, randomised, multicentre trial to assess short- and long-term results after laparoscopic and conventional resection of colorectal carcinoma

Completed
Conditions
Colonic and upper rectal cancer
Cancer
Malignant neoplasm of colon
Registration Number
ISRCTN18106465
Lead Sponsor
Charité - University Medicine Berlin (Germany)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
1200
Inclusion Criteria

1. Both males and females
2. Tumour located in the upper rectum (above 12 cm from the anal verge) or the colon
3. Scheduled for right hemicolectomy, sigmoidectomy, or anterior rectal resection

Exclusion Criteria

1. Adenocarcinoma of the transverse colon or the colonic flexures necessitating extended left or right 2. Hemicolectomy or subtotal colectomy
3. Distant metastasis (i.e. liver or lung)
4. Contraindications to pneumoperitoneum
5. Acute intestinal obstruction
6. Perforation
7. Abscess
8. Malignant disease in the past 5 years (excluding skin basiloma or carcinoma in situ of the cervix)
9. Synchronous adenocarcinoma of the colorectum
10. Pregnancy
11. Age below 18 years
12. Unwilling to consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath